Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways

Apoptosis: A Review of Programmed Cell Death

Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853 · see citing works

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444 · see citing works

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677 · see citing works

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574 · see citing works

Coronavirus as a possible cause of severe acute respiratory syndrome

Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916 · see citing works

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061 · see citing works

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Assiri, A., Al-Tawfiq, J. A., Al-Rabeeah, A. A., Al-Rabiah, F. A., Al-Hajjar, S., Al-Barrak, A., Flemban, H., Al-Nassir, W. N., Balkhy, H. H., Al-Hakeem, R. F., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70204-4 · Cited by 1,435 · see citing works

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

Cheng, V. C. C., Lau, S. K. P., Woo, P. C. Y., & Yuen, K. Y. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00023-07 · Cited by 1,192 · see citing works

Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection

Doitsh, G., Galloway, N. L. K., Geng, X., Yang, Z., Monroe, K. M., Zepeda, O., Hunt, P. W., Hatano, H., Sowinski, S., Muñoz-Arias, I., et al. (2013) · Nature · doi:10.1038/nature12940 · Cited by 1,181 · see citing works

Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis

Slee, E. A., Adrain, C., & Martin, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008363200 · Cited by 1,118 · see citing works

Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease

Chan, J. F., Lau, S. K. P., To, K. K., Cheng, V. C., Woo, P. C. Y., & Yuen, K. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-14 · Cited by 880 · see citing works

Interspecies transmission and emergence of novel viruses: lessons from bats and birds

Chan, J. F., To, K. K., Tse, H., Jin, D., & Yuen, K. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.05.005 · Cited by 616 · see citing works

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

Chan, J. F., Yao, Y., Yeung, M. L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yü, P., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 607 · see citing works

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012

Bermingham, A., Chand, M. A., Brown, C. S., Aarons, E., Tong, C. Y. W., Langrish, C., Höschler, K., Brown, K. E., Galiano, M., Myers, R. E., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.40.20290-en · Cited by 468 · see citing works

Rapid generation of a mouse model for Middle East respiratory syndrome

Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S., Fett, C., Zhao, J., Gale, M., Baric, R. S., Enjuanes, L., Gallagher, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323279111 · Cited by 452 · see citing works

Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis

Zhou, J., Chu, H., Li, C., Wong, B. H., Cheng, Z., Poon, V. K., Sun, T., Lau, C. C.-Y., Wong, K. K. Y., Chan, J. Y. W., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit504 · Cited by 425 · see citing works

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment

Lau, S. K. P., Lau, C. C. Y., Chan, K., Li, C. P. Y., Chen, H., Jin, D., Chan, J. F., Woo, P. C. Y., & Yuen, K. (2013) · Journal of General Virology · doi:10.1099/vir.0.055533-0 · Cited by 393 · see citing works

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

Chan, J. F., Chan, K., Kao, R. Y. T., To, K. K., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385 · see citing works

MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment

de Wilde, A. H., Raj, V. S., Oudshoorn, D., Bestebroer, T. M., van Nieuwkoop, S., Limpens, R. W. A. L., Posthuma, C. C., van der Meer, Y., Bárcena, M., Haagmans, B. L., et al. (2013) · Journal of General Virology · doi:10.1099/vir.0.052910-0 · Cited by 343 · see citing works

T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice

Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340 · see citing works

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

de Wit, E., Rasmussen, A. L., Falzarano, D., Bushmaker, T., Feldmann, F., Brining, D. L., Fischer, E. R., Martellaro, C., Okumura, A., Chang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310744110 · Cited by 312 · see citing works

Hospital-Associated Outbreak of Middle East Respiratory Syndrome Coronavirus: A Serologic, Epidemiologic, and Clinical Description

Alabdallat, M., Payne, D. C., Alqasrawi, S., Rha, B., Tohme, R. A., Abedi, G. R., Nsour, M. A., Iblan, I., Jarour, N., Farag, N. H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu359 · Cited by 308 · see citing works

Pathogenic Influenza Viruses and Coronaviruses Utilize Similar and Contrasting Approaches To Control Interferon-Stimulated Gene Responses

Menachery, V. D., Eisfeld, A. J., Schäfer, A., Josset, L., Sims, A. M., Proll, S. C., Fan, S., Li, C., Neumann, G., Tilton, S. C., et al. (2014) · mBio · doi:10.1128/mbio.01174-14 · Cited by 307 · see citing works

Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus

Josset, L., Menachery, V. D., Gralinski, L. E., Agnihothram, S., Sova, P., Carter, V. S., Yount, B. L., Graham, R. L., Baric, R. S., & Katze, M. G. (2013) · mBio · doi:10.1128/mbio.00165-13 · Cited by 297 · see citing works

Replication and Shedding of MERS-CoV in Upper Respiratory Tract of Inoculated Dromedary Camels

Adney, D. R., van Doremalen, N., Brown, V. R., Bushmaker, T., Scott, D. P., de Wit, E., Bowen, R. A., & Munster, V. J. (2014) · Emerging infectious diseases · doi:10.3201/eid2012.141280 · Cited by 285 · see citing works

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists

Yang, Y., Zhang, L., Geng, H., Deng, Y. L., Huang, B., Yin, G., Zhao, Z., & Tan, W. (2013) · Protein & Cell · doi:10.1007/s13238-013-3096-8 · Cited by 273 · see citing works

Effects of severe acute respiratory syndrome (SARS) coronavirus infection on peripheral blood lymphocytes and their subsets

He, Z., Zhao, C., Dong, Q., Zhuang, H., Song, S., Peng, G., & Dwyer, D. E. (2005) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2004.07.014 · Cited by 257 · see citing works

Distinct Immune Response in Two MERS-CoV-Infected Patients: Can We Go from Bench to Bedside?

Faure, E., Poissy, J., Goffard, A., Fournier, C., Kipnis, É., Titécat, M., Bortolotti, P., Martinez, L., Dubucquoi, S., Dessein, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088716 · Cited by 249 · see citing works

Differential Cell Line Susceptibility to the Emerging Novel Human Betacoronavirus 2c EMC/2012: Implications for Disease Pathogenesis and Clinical Manifestation

Chan, J. F., Chan, K., Choi, G. K.-Y., To, K. K., Tse, H., Cai, J., Yeung, M. L., Cheng, V. C., Chen, H., Che, X.-Y., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit123 · Cited by 219 · see citing works

Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset

Falzarano, D., de Wit, E., Feldmann, F., Rasmussen, A. L., Okumura, A., Peng, X., Thomas, M. J., van Doremalen, N., Haddock, E., Nagy, L., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004250 · Cited by 210 · see citing works

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes

Torimoto, Y., Dang, N. H., Vivier, É., Tanaka, T., Schlossman, S. F., & Morimoto, C. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.8.2514 · Cited by 206 · see citing works

Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines

Müller, M. A., Raj, V. S., Muth, D., Meyer, B., Kallies, S., Smits, S. L., Wollny, R., Bestebroer, T. M., Specht, S., Suliman, T., et al. (2012) · mBio · doi:10.1128/mbio.00515-12 · Cited by 206 · see citing works

Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist

Niemeyer, D., Zillinger, T., Muth, D., Zielecki, F., Horvath, G. L., Suliman, T., Barchet, W., Weber, F., Drosten, C., & Müller, M. A. (2013) · Journal of Virology · doi:10.1128/jvi.01845-13 · Cited by 190 · see citing works

Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response

Chu, H., Zhou, J., Wong, B. H., Li, C., Cheng, Z., Lin, X., Poon, V. K., Sun, T., Lau, C. C.-Y., Chan, J. F., et al. (2014) · Virology · doi:10.1016/j.virol.2014.02.018 · Cited by 179 · see citing works

The costimulatory activity of the CD26 antigen requires dipeptidyl peptidase IV enzymatic activity.

Tanaka, T., Kameoka, J., Yaron, A., Schlossman, S. F., & Morimoto, C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4586 · Cited by 176 · see citing works

CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO

Ishii, T., Ohnuma, K., Murakami, A., Takasawa, N., Kobayashi, S., Dang, N. H., Schlossman, S. F., & Morimoto, C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211439098 · Cited by 172 · see citing works

Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?

Chan, J. F., Li, K. S. M., To, K. K., Cheng, V. C., Chen, H., & Yuen, K. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.10.002 · Cited by 162 · see citing works

Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease

Yang, X., Chen, X., Bian, G., Tu, J., Xing, Y., Wang, Y., & Chen, Z. (2013) · Journal of General Virology · doi:10.1099/vir.0.059014-0 · Cited by 155 · see citing works

Evasion by Stealth: Inefficient Immune Activation Underlies Poor T Cell Response and Severe Disease in SARS-CoV-Infected Mice

Zhao, J., Zhao, J., van Rooijen, N., & Perlman, S. M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000636 · Cited by 151 · see citing works

Sensitive and Specific Monoclonal Antibody-Based Capture Enzyme Immunoassay for Detection of Nucleocapsid Antigen in Sera from Patients with Severe Acute Respiratory Syndrome

Che, X.-Y., Qiu, L., Pan, Y.-X., Wen, K., Hao, W., Zhang, L.-Y., Wang, Y.-D., Liao, Z.-Y., Xu, H., Cheng, V. C., et al. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.6.2629-2635.2004 · Cited by 128 · see citing works

Detection of SARS Coronavirus in Plasma by Real-Time RT-PCR

Grant, P. R., Garson, J. A., Tedder, R. S., Chan, P. K. S., Tam, J. S., & Sung, J. J. �. (2003) · New England Journal of Medicine · doi:10.1056/nejm200312183492522 · Cited by 126 · see citing works

An Animal Model of MERS Produced by Infection of Rhesus Macaques With MERS Coronavirus

Yao, Y., Bao, L., Deng, W., Xu, L., Li, F., Lv, Q., Yü, P., Chen, T., Xu, Y., Zhu, H., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit590 · Cited by 125 · see citing works

In-vitro renal epithelial cell infection reveals a viral kidney tropism as a potential mechanism for acute renal failure during Middle East Respiratory Syndrome (MERS) Coronavirus infection

Eckerle, I., Müller, M. A., Kallies, S., Gotthardt, D. N., & Drosten, C. (2013) · Virology Journal · doi:10.1186/1743-422x-10-359 · Cited by 120 · see citing works

Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses

Chan, J. F., Choi, G. K.-Y., Tsang, A. K. L., Tee, K., Lam, H., Yip, C. C., To, K. K., Cheng, V. C., Yeung, M. L., Lau, S. K. P., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01224-15 · Cited by 89 · see citing works

Tetherin/BST-2 Is Essential for the Formation of the Intracellular Virus-Containing Compartment in HIV-Infected Macrophages

Chu, H., Wang, J.-J., Qi, M., Yoon, J.-J., Chen, X., Wen, X., Hammonds, J. E., Ding, L., & Spearman, P. W. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.07.011 · Cited by 85 · see citing works

Kinetics and pattern of viral excretion in biological specimens of two MERS-CoV cases

Poissy, J., Goffard, A., Parmentier-Decrucq, E., Favory, R., Kauv, M., Kipnis, É., Mathieu, D., & Guery, B. P. (2014) · Journal of Clinical Virology · doi:10.1016/j.jcv.2014.07.002 · Cited by 82 · see citing works

Clinical and Laboratory Findings of the First Imported Case of Middle East Respiratory Syndrome Coronavirus to the United States

Kapoor, M., Pringle, K. D., Kumar, A., Dearth, S. M., Liu, L., Lovchik, J. C., Perez, O., Pontones, P., Richards, S. M., Yeadon-Fagbohun, J., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu635 · Cited by 77 · see citing works

Middle East respiratory syndrome coronavirus (MERS-CoV) infections in two returning travellers in the Netherlands, May 2014

Kraaij‐Dirkzwager, M., Timen, A., Dirksen, K., Gelinck, L. B. S., Leyten, E. M. S., Groeneveld, P. H. P., Jansen, C. L., Jonges, M., Raj, V. S., Thurkow, I., et al. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.21.20817 · Cited by 75 · see citing works

Bilateral Entry and Release of Middle East Respiratory Syndrome Coronavirus Induces Profound Apoptosis of Human Bronchial Epithelial Cells

Tao, X., Hill, T. E., Morimoto, C., Peters, C. J., Ksiazek, T. G., & Tseng, C.-T. K. (2013) · Journal of Virology · doi:10.1128/jvi.01562-13 · Cited by 73 · see citing works

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066 · see citing works

Clinical and immunological features of severe and moderate coronavirus disease 2019

Chen, G., Wu, D., Guo, W., Cao, Y., Huang, D., Wang, H., Wang, T., Zhang, X., Chen, H., Yu, H., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137244 · Cited by 4,750 · see citing works

Extrapulmonary manifestations of COVID-19

Gupta, A., Madhavan, M. V., Sehgal, K., Nair, N., Mahajan, S., Sehrawat, T. S., Bikdeli, B., Ahluwalia, N., Ausiello, J. C., Wan, E. Y., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0968-3 · Cited by 3,185 · see citing works

Pathogenic human coronavirus infections: Causes and consequences of cytokine storm and immunopathology

Channappanavar, R., & Perlman, S. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0629-x · Cited by 2,524 · see citing works

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · see citing works

Coronaviruses — drug discovery and therapeutic options

Zumla, A. I., Chan, J. F., Azhar, E. I., Hui, D. S. C., & Yuen, K. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,689 · see citing works

Longitudinal Characteristics of Lymphocyte Responses and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients

Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., Zhao, L., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102763 · Cited by 1,705 · see citing works

Immunology of COVID-19: Current State of the Science

Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623 · see citing works

The COVID-19 pandemic

Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,567 · see citing works

From SARS to MERS, Thrusting Coronaviruses into the Spotlight

Song, Z., Xu, Y., Bao, L., Zhang, L., Yü, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,268 · see citing works

Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up

Wang, L., He, W., Yu, X., Hu, D., Bao, M., Liu, H., Zhou, J., & Jiang, H. X. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.019 · Cited by 1,228 · see citing works

SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

Costela-Ruiz, V. J., Montes, R. I., Puerta, J. M., Ruíz, C., & Melguizo‐Rodríguez, L. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.001 · Cited by 1,110 · see citing works

Human Coronavirus: Host-Pathogen Interaction

Fung, T. S., & Liu, D. X. (2019) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-115759 · Cited by 964 · see citing works

Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)

Umakanthan, S., Sahu, P. K., Ranade, A. V., Bukelo, M. M., Rao, J. S., Abrahão‐Machado, L. F., Dahal, S., Kumar, H. D. V., & Kv, D. (2020) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2020-138234 · Cited by 737 · see citing works

Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China

Zhang, G., Hu, C., Luo, L., Fang, F., Chen, Y., Li, J., Peng, Z., & Pan, H. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104364 · Cited by 691 · see citing works

Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19

Chu, H., Chan, J. F., Wang, Y., Yuen, T. T., Chai, Y., Hou, Y., Shuai, H., Yang, D., Hu, B., Huang, X., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa410 · Cited by 659 · see citing works

Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV

Liu, J., Zheng, X., Tong, Q., Li, W., Wang, B., Sutter, K., Trilling, M., Lu, M., Dittmer, U., & Yang, D. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25709 · Cited by 618 · see citing works

COVID-19: Melatonin as a potential adjuvant treatment

Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., Liu, C., & Reiter, R. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117583 · Cited by 619 · see citing works

The signal pathways and treatment of cytokine storm in COVID-19

Yang, L., Xie, X., Tu, Z., Fu, J., Xu, D., & Zhou, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00679-0 · Cited by 599 · see citing works

Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset

Chan, J. F., Yao, Y., Yeung, M. L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yü, P., et al. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 607 · see citing works

Human Coronaviruses: A Review of Virus–Host Interactions

Lim, Y. X., Ng, Y. W., Tam, J. P., & Liu, D. X. (2016) · Diseases · doi:10.3390/diseases4030026 · Cited by 585 · see citing works

Coagulopathy in COVID‐19

Iba, T., Levy, J. H., Levi, M. M., & Thachil, J. V. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14975 · Cited by 594 · see citing works

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

Channappanavar, R., Fehr, A. R., Zheng, J. H., Wohlford-Lenane, C., Abrahante, J. E., Mack, M., Sompallae, R. R., McCray, P. B., Meyerholz, D. K., & Perlman, S. M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126363 · Cited by 556 · see citing works

Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., Wang, M., Li, S., Morita, H., Altunbulakli, C., et al. (2020) · Allergy · doi:10.1111/all.14429 · Cited by 542 · see citing works

The molecular virology of coronaviruses

Hartenian, E., Nandakumar, D., Lari, A., Ly, M., Tucker, J. M., & Glaunsinger, B. A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.013930 · Cited by 513 · see citing works

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV

Liu, W. J., Zhao, M. J., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 397 · see citing works

Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China

Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., Ni, Z., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.003 · Cited by 376 · see citing works

Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

Zhou, J., Li, C., Zhao, G., Chu, H., Wang, D., Yan, H. H.-N., Poon, V. K., Wen, L., Wong, B. H., Zhao, X., et al. (2017) · Science Advances · doi:10.1126/sciadv.aao4966 · Cited by 376 · see citing works

Effective inhibition of MERS-CoV infection by resveratrol

Lin, S., Ho, C., Chuo, W., Li, S., Wang, T. T., & Lin, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2253-8 · Cited by 358 · see citing works

Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection

Liang, Y., Wang, M., Chien, C., Yarmishyn, A. A., Yang, Y.-P., Lai, W.-Y., Luo, Y., Lin, Y.-T., Chen, Y.-J., Chang, P., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01022 · Cited by 339 · see citing works

Lessons for COVID-19 immunity from other coronavirus infections

Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317 · see citing works

Autoinflammatory and autoimmune conditions at the crossroad of COVID-19

Rodríguez, Y., Novelli, L., Rojas, M., Santis, M. D., Acosta‐Ampudia, Y., Monsalve, D. M., Ramı́rez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 312 · see citing works

From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses

Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 308 · see citing works

Overview of lethal human coronaviruses

Chen, B., Tian, E.-K., He, B., Tian, L., Han, R., Wang, S., Xiang, Q., Zhang, S., Arnaout, T. E., & Cheng, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0190-2 · Cited by 299 · see citing works

Middle East Respiratory Syndrome: Emergence of a Pathogenic Human Coronavirus

Fehr, A. R., Channappanavar, R., & Perlman, S. M. (2016) · Annual Review of Medicine · doi:10.1146/annurev-med-051215-031152 · Cited by 293 · see citing works

Characterization of the Lipidomic Profile of Human Coronavirus-Infected Cells: Implications for Lipid Metabolism Remodeling upon Coronavirus Replication

Yan, B., Chu, H., Yang, D., Sze, K. H., Lai, P.-M., Yuan, S., Shuai, H., Wang, Y., Kao, R. Y. T., Chan, J. F., et al. (2019) · Viruses · doi:10.3390/v11010073 · Cited by 267 · see citing works

Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses

Zhao, J., Alshukairi, A. N., Baharoon, S. A., Ahmed, W., Bokhari, A. A., Nehdi, A., Layqah, L. A., Alghamdi, M., Algethamy, M., Dada, A. M., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aan5393 · Cited by 263 · see citing works

SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

Yuan, S., Chu, H., Chan, J. F., Ye, Z., Wen, L., Yan, B., Lai, P.-M., Tee, K., Huang, J., Chen, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08015-x · Cited by 253 · see citing works

Laboratory abnormalities in children with novel coronavirus disease 2019

Henry, B. M., Lippi, G., & Plebani, M. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0272 · Cited by 252 · see citing works

Chemokines and chemokine receptors during COVID-19 infection

Khalil, B. A., Elemam, N. M., & Maghazachi, A. A. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.01.034 · Cited by 246 · see citing works

The clinical course and its correlated immune status in COVID-19 pneumonia

He, R., Lu, Z., Zhang, L., Fan, T. T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104361 · Cited by 235 · see citing works

Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus

Yong, C. Y., Ong, H. K., Yeap, S. K., Ho, K. L., & Tan, W. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01781 · Cited by 224 · see citing works

Devilishly radical NETwork in COVID-19: Oxidative stress, neutrophil extracellular traps (NETs), and T cell suppression

Schönrich, G., Raftery, M. J., & Samstag, Y. (2020) · Advances in Biological Regulation · doi:10.1016/j.jbior.2020.100741 · Cited by 221 · see citing works

An overview on the seven pathogenic human coronaviruses

Kesheh, M. M., Hosseini, P., Soltani, S., & Zandi, M. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2282 · Cited by 212 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection

Synowiec, A., Szczepański, A., Barreto-Durán, E., Lie, L. K., & Pyrć, K. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00133-20 · Cited by 221 · see citing works

The Immune Response and Immunopathology of COVID-19

Mortaz, E., Tabarsi, P., Varahram, M., Folkerts, G., & Adcock, I. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02037 · Cited by 206 · see citing works

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

Lee, S., Channappanavar, R., & Kanneganti, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.005 · Cited by 205 · see citing works

Activation of NF-κB and induction of proinflammatory cytokine expressions mediated by ORF7a protein of SARS-CoV-2

Su, C.-M., Wang, L., & Yoo, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-92941-2 · Cited by 204 · see citing works

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development

Mubarak, A., Alturaiki, W., & Hemida, M. G. (2019) · Journal of Immunology Research · doi:10.1155/2019/6491738 · Cited by 199 · see citing works

Clinical Features of Patients Infected with the 2019 Novel Coronavirus (COVID-19) in Shanghai, ChinaPreprint

Cao, M., Zhang, D., Wang, Y., Lu, Y., Zhu, X., Li, Y., Xue, H., Lin, Y.-X., Zhang, M., Sun, Y., et al. (2020) · medRxiv · doi:10.1101/2020.03.04.20030395 · Cited by 199 · see citing works

Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4 -transgenic mice infected with MERS-CoV

Jiang, Y., Zhao, G., Song, N., Li, P., Chen, Y., Guo, Y., Li, J., Du, L., Jiang, S., Guo, R., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0063-8 · Cited by 195 · see citing works

MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape

Menachery, V. D., Schäfer, A., Burnum-Johnson, K., Mitchell, H. D., Eisfeld, A. J., Walters, K., Nicora, C., Purvine, S. O., Casey, C., Monroe, M. E., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706928115 · Cited by 193 · see citing works

Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells

Chu, H., Chan, C.-M., Zhang, X., Wang, Y., Yuan, S., Zhou, J., Au-Yeung, R. K. H., Sze, K. H., Yang, D., Shuai, H., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001897 · Cited by 191 · see citing works

Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract

Meyerholz, D. K., Lambertz, A. M., & McCray, P. B. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.014 · Cited by 181 · see citing works

Attenuated Interferon and Proinflammatory Response in SARS-CoV-2–Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation

Yang, D., Chu, H., Hou, Y., Chai, Y., Shuai, H., Lee, A. C.-Y., Zhang, X., Wang, Y., Hu, B., Huang, X., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa356 · Cited by 179 · see citing works

MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2

Yeung, M. L., Yao, Y., Jia, L., Chan, J. F., Chan, K., Cheung, K.-F., Chen, H., Poon, V. K., Tsang, A. K. L., To, K. K., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.4 · Cited by 175 · see citing works

Animal and translational models of SARS-CoV-2 infection and COVID-19

Johansen, M. D., Irving, A. T., Montagutelli, X., Tate, M. D., Rudloff, I., Nold, M. F., Hansbro, N. G., Kim, R., Donovan, C., Liu, G., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00340-z · Cited by 169 · see citing works

ACE2-independent infection of T lymphocytes by SARS-CoV-2

Shen, X.-R., Geng, R., Li, Q., Chen, Y., Li, S., Wang, Q. M., Min, J., Yang, Y. P., Li, B., Jiang, R.-D., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00919-x · Cited by 171 · see citing works

Scoring Systems for Predicting Mortality for Severe Patients with COVID-19

Shang, Y., Liu, T., Wei, Y., Li, J., Shao, L., Liu, M., Zhang, Y., Zhao, Z., Xu, H., Peng, Z., et al. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100426 · Cited by 172 · see citing works

Modeling the viral dynamics of SARS-CoV-2 infection

Wang, S., Pan, Y., Wang, Q., Miao, H., Brown, A. N., & Rong, L. (2020) · Mathematical Biosciences · doi:10.1016/j.mbs.2020.108438 · Cited by 170 · see citing works

Changes of hematological and immunological parameters in COVID-19 patients

Yuan, X., Huang, W., Ye, B., Chen, C., Huang, R., Wu, F., Qin, W., Zhang, W., & Hu, J. (2020) · International Journal of Hematology · doi:10.1007/s12185-020-02930-w · Cited by 171 · see citing works

Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?

Musa, S. (2020) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2020.03.002 · Cited by 170 · see citing works

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration

Chen, R., Lan, Z., Ye, J., Pang, L., Liu, Y., Wu, W., Qin, X., Guo, Y., & Zhang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.589095 · Cited by 162 · see citing works

Molecular Basis of Coronavirus Virulence and Vaccine Development

Enjuanes, L., Zúñiga, S., Castaño-Rodríguez, C., Gutierrez-Alvarez, F. J., Cantón, J., & Sola, I. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2016.08.003 · Cited by 158 · see citing works

Pharmacological Therapeutics Targeting RNA-Dependent RNA Polymerase, Proteinase and Spike Protein: From Mechanistic Studies to Clinical Trials for COVID-19

Huang, J., Song, W., Huang, H., & Sun, Q. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041131 · Cited by 161 · see citing works

Retrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients

Yao, Q., Wang, P., Wang, X., Qie, G., Meng, M., Tong, X., Bai, X., Ding, M., Liu, W., Keke, L., et al. (2020) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.15312 · Cited by 152 · see citing works

Immune responses during COVID-19 infection

Melenotte, C., Silvin, A., Goubet, A., Lahmar, I., Dubuisson, A., Zumla, A. I., Raoult, D., Merad-Boudia, M., Gachot, B., Henon, C., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1807836 · Cited by 162 · see citing works

Infectability of Human BrainSphere Neurons Suggests Neurotropism of SARS-CoV-2*

Bullen, C. K. (2020) · ALTEX · doi:10.14573/altex.2006111 · Cited by 146 · see citing works

Lymphopenia an important immunological abnormality in patients with COVID‐19: Possible mechanisms

Jafarzadeh, A., Jafarzadeh, S., Nozari, P., Mokhtari, P., & Nemati, M. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12967 · Cited by 146 · see citing works

Host and viral determinants for efficient SARS-CoV-2 infection of the human lung

Chu, H., Hu, B., Huang, X., Chai, Y., Zhou, D., Wang, Y., Shuai, H., Yang, D., Hou, Y., Zhang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20457-w · Cited by 141 · see citing works

SARS-CoV-2 productively infects primary human immune system cells in vitro and in COVID-19 patients

Pontelli, M. C., Castro, Í. A., Júnior, R. B. M., Serra, L. L., Veras, F. P., Nascimento, D. C., Silva, C. M. S., Cardoso, R. D. S., Rosales, R., Gomes, R., et al. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac021 · Cited by 140 · see citing works

Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy

Jiang, Y.-Z., Rubin, L., Peng, T., Liu, L., Xing, X., Lazarovici, P., & Zheng, W. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59272 · Cited by 141 · see citing works

Predictive factors for pneumonia development and progression to respiratory failure in MERS-CoV infected patients

Ko, J., Park, G. E., Lee, J. Y., Lee, J., Cho, S. Y., Ha, Y. E., Kang, C., Kang, J., Kim, Y., Huh, H. J., et al. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.08.005 · Cited by 139 · see citing works

COVID-19 and the role of cytokines in this disease

Hasanvand, A. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00992-2 · Cited by 135 · see citing works

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

Ricke, D. O. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.640093 · Cited by 132 · see citing works

ACE2: the molecular doorway to SARS-CoV-2

Medina-Enríquez, M. M., López‐León, S., Carlos-Escalante, J. A., Torres, Z. A., Cuapio, A., & Wegman-Ostrosky, T. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00519-8 · Cited by 134 · see citing works

High Prevalence of MERS-CoV Infection in Camel Workers in Saudi Arabia

Alshukairi, A. N., Zheng, J. H., Zhao, J., Nehdi, A., Baharoon, S. A., Layqah, L. A., Bokhari, A. A., Johani, S. M. A., Samman, N., Boudjelal, M., et al. (2018) · mBio · doi:10.1128/mbio.01985-18 · Cited by 131 · see citing works

A Novel Combination of Vitamin C, Curcumin and Glycyrrhizic Acid Potentially Regulates Immune and Inflammatory Response Associated with Coronavirus Infections: A Perspective from System Biology Analysis

Chen, L., Hu, C., Hood, M. M., Zhang, X., Zhang, L., Kan, J., & Du, J. C. (2020) · Nutrients · doi:10.3390/nu12041193 · Cited by 131 · see citing works

The immuno-oncological challenge of COVID-19

Derosa, L., Melenotte, C., Griscelli, F., Gachot, B., Marabelle, A., Kroemer, G., & Zitvogel, L. (2020) · Nature Cancer · doi:10.1038/s43018-020-00122-3 · Cited by 133 · see citing works

Lymphopenia Caused by Virus Infections and the Mechanisms Beyond

Guo, Z., Zhang, Z., Prajapati, M., & Li, Y. (2021) · Viruses · doi:10.3390/v13091876 · Cited by 134 · see citing works

Clinical Characteristics of Children With COVID-19: A Meta-Analysis

Ding, Y., Yan, H., & Guo, W. (2020) · Frontiers in Pediatrics · doi:10.3389/fped.2020.00431 · Cited by 127 · see citing works

Isolation, Sequence, Infectivity, and Replication Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2

Banerjee, A., Nasir, J. A., Budylowski, P., Yip, L., Aftanas, P., Christie, N., Ghalami, A., Baid, K., Raphenya, A. R., Hirota, J. A., et al. (2020) · Emerging infectious diseases · doi:10.3201/eid2609.201495 · Cited by 126 · see citing works

MERS coronavirus outbreak: Implications for emerging viral infections

Al‐Omari, A., Rabaan, A. A., Salih, S., Al‐Tawfiq, J. A., & Memish, Z. A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.011 · Cited by 122 · see citing works

MERS-CoV infection is associated with downregulation of genes encoding Th1 and Th2 cytokines/chemokines and elevated inflammatory innate immune response in the lower respiratory tract

Alosaimi, B., Hamed, M. E., Naeem, A., Alsharef, A. A., Alqahtani, S. Y., Aldosari, K., Alamri, A. A., Al-Eisa, K., Khojah, T., Assiri, A. M., et al. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154895 · Cited by 116 · see citing works

Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction

Wang, J., Yang, X., Li, Y., Huang, J., Jiang, J., & Su, N. (2021) · Virology Journal · doi:10.1186/s12985-021-01588-y · Cited by 113 · see citing works

Predictors for imaging progression on chest CT from coronavirus disease 2019 (COVID-19) patients

Yang, Z., Shi, J. H., He, Z., Lü, Y., Xu, Q., Ye, C., Chen, S., Tang, B., Yin, K., Lu, Y., et al. (2020) · Aging · doi:10.18632/aging.102999 · Cited by 108 · see citing works

Abnormal immunity of non-survivors with COVID-19: predictors for mortality

Zhao, Y., Nie, H., Hu, K., Wu, X., Zhang, Y., Wang, M. E., Wang, T., Zheng, Z., Li, X., & Zeng, S. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00723-1 · Cited by 106 · see citing works

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study

Zheng, Y., Zhang, Y., Chi, H., Chen, S., Peng, M., Lifei, L., Chen, L., Li, J., Shen, B., & Wang, D. (2020) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2020-0377 · Cited by 105 · see citing works

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

Ostaszewski, M., Niarakis, A., Mazein, A., Kuperstein, I., Phair, R. D., Resendiz, A. O., Singh, V., Aghamiri, S. S., Acencio, M. L., Glaab, E., et al. (2021) · Molecular Systems Biology · doi:10.15252/msb.202110387 · Cited by 100 · see citing works

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections

Zhang, Y.-Y., Li, B.-R., & Ning, B. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02033 · Cited by 103 · see citing works

SARS coronavirus 2: from genome to infectome

Rastogi, M., Pandey, N., Shukla, A., & Singh, S. K. (2020) · Respiratory Research · doi:10.1186/s12931-020-01581-z · Cited by 98 · see citing works

Advances in gene-based vaccine platforms to address the COVID-19 pandemic

Pushparajah, D., Jimenez, S., Wong, S. L., Alattas, H., Nafissi, N., & Slavcev, R. A. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.01.003 · Cited by 98 · see citing works

Recent Aspects on the Pathogenesis Mechanism, Animal Models and Novel Therapeutic Interventions for Middle East Respiratory Syndrome Coronavirus Infections

Skariyachan, S., Challapilli, S. B., Packirisamy, S., Kumargowda, S. T., & Sridhar, V. S. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00569 · Cited by 99 · see citing works

Clinical characteristics of 34 COVID-19 patients admitted to intensive care unit in Hangzhou, China

Zheng, Y. F., Sun, L., Xu, M., Pan, J., Zhang, Y., Fang, X., Fang, Q., & Cai, H. (2020) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000174 · Cited by 96 · see citing works

Pregnancy and COVID-19: management and challenges

Wenling, Y., Qiu, J., Xiao, Z., & Ouyang, S. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062062 · Cited by 96 · see citing works

Elevated plasma IL-6 and CRP levels are associated with adverse clinical outcomes and death in critically ill SARS-CoV-2 patients: inflammatory response of SARS-CoV-2 patients

Lavillegrand, J., Garnier, M., Spaeth, A., Mario, N., Hariri, G., Pilon, A., Berti, E., Fieux, F., Thietart, S., Urbina, T., et al. (2021) · Annals of Intensive Care · doi:10.1186/s13613-020-00798-x · Cited by 94 · see citing works

SARS-CoV-2 Induces Lymphocytopenia by Promoting Inflammation and Decimates Secondary Lymphoid Organs

Xiang, Q., Feng, Z., Diao, B., Tu, C., Qiao, Q., Yang, H., Zhang, Y., Wang, G., Wang, H., Wang, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661052 · Cited by 96 · see citing works

Risk factors related to hepatic injury in patients with corona virus disease 2019Preprint

Lu, L., Li, S., Xu, M., Yu, P., Zheng, S., Duan, Z., Liu, J., Chen, Y., & Li, J. (2020) · medRxiv · doi:10.1101/2020.02.28.20028514 · Cited by 98 · see citing works

Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis

Zhou, J., Chu, H., Chan, J. F., & Yuen, K. (2015) · Virology Journal · doi:10.1186/s12985-015-0446-6 · Cited by 87 · see citing works

Discovery of T-Cell Infection and Apoptosis by Middle East Respiratory Syndrome Coronavirus

Ying, T., Li, W., & Dimitrov, D. S. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv381 · Cited by 42 · see citing works

REVIEW Open Access Middle East respiratory syndrome

(2016)

Massive Infektion und alveolare Schädigung der humanen Lunge durch das Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Becher, A., von Recum, J., Schierhorn, K. L., Wolff, T., Tönnies, M., Neudecker, J., Rückert, J. C., Schneider, P., Gruber, A., Suttorp, N., et al. (2015) · Pneumologie · doi:10.1055/s-0035-1548632

CD8 + T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome

Coleman, C. M., Sisk, J. M., Halász, G., Zhong, J., Beck, S. E., Matthews, K. L., Venkataraman, T., Rajagopalan, S., Kyratsous, C. A., & Frieman, M. B. (2016) · Journal of Virology · doi:10.1128/jvi.01825-16 · Cited by 65 · see citing works